DexCom, Inc. (DXCM)
NASDAQ: DXCM · IEX Real-Time Price · USD
125.88
-1.51 (-1.19%)
At close: May 1, 2024, 4:00 PM
126.41
+0.53 (0.42%)
After-hours: May 1, 2024, 7:50 PM EDT
DexCom Employees
DexCom had 9,600 employees on December 31, 2023. The number of employees increased by 2,000 or 26.32% compared to the previous year.
Employees
9,600
Change (1Y)
2,000
Growth (1Y)
26.32%
Revenue / Employee
$396,021
Profits / Employee
$66,594
Market Cap
50.06B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
IQVIA Holdings | 87,000 |
Becton, Dickinson and Company | 73,000 |
McKesson | 51,000 |
Takeda Pharmaceutical | 49,095 |
Cencora | 46,000 |
Edwards Lifesciences | 19,800 |
Gilead Sciences | 18,000 |
Zoetis | 14,100 |
DXCM News
- 6 days ago - Dexcom Reports First Quarter 2024 Financial Results - Business Wire
- 21 days ago - MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems With its Remote Care Management Platform - Business Wire
- 21 days ago - This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? - Market Watch
- 4 weeks ago - Dexcom Publishes Annual Sustainability Report - Business Wire
- 4 weeks ago - Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time - Business Wire
- 2 months ago - Dexcom announces its first ever over-the-counter CGM Stelo has been cleared by the FDA - CNBC
- 2 months ago - US FDA clears use of first over-the-counter continuous glucose monitor - Reuters
- 2 months ago - Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter - Business Wire